Hospital in Minsk to use suPAR in CKD and sepsis patients

The 9th City Clinical Hospital Minsk, Belarus has entered an agreement with ViroGates for the use of suPARnostic® Quick Triage in clinical routine practice for the detection and severity assessment of Chronic Kidney Disease (CKD) and sepsis patients.

The hospital is according to its own information the largest kidney transplant centre in Eastern Europe and conducts approx. 200 kidney transplants per year.

Doctors O. Rummo (Director of the Republican Center for Organ Transplantation) and A. Kalachyk (Head of Nephrology and Renal Replacement Therapy Unit) from the 9th City Hospital Minsk states in a written comment:

“We are pleased to inform that the detection of soluble urokinase plasminogen activating receptor (suPAR) (commercial kit suparnostic® Quick Triage, produced by ViroGates, Denmark) has been implemented in our routine clinical practice.
Based on the literature we strongly believe that suPAR is the robust and earliest biomarker of CKD progression but also can be used as a new prognostic biomarker in kidney transplant recipient (for example in FSGS recurrence) and patients with sepsis.
We also declare that it will be used at our hospital for routine clinical decision making but at the same time as the largest kidney transplant center in the Eastern Europe (with up to 200 kidney transplant cases per year) we continue to investigate the predictive value of suPAR in different clinical situation after kidney transplantation and will drive our own study for it.”